Global Rosuvastatin Market Professional Survey Report 2016
- QYR584597
- 157 Pages
- May 2016
- Pharmaceuticals
Mainly covers the following product types
Injection
Freeze-dried powder
The segment applications including
Hospital use
Clinic
Others
Segment regions including (the separated region report can also be offered)
USA
China
UK
France
Switzerland
Japan
Germany
Canada
The players list (Partly, Players you are interested in can also be added)
Pfizer
Teva
AstraZeneca UK Limited
Novartis
Mylan
Squibb
Sandoz
Hikma Pharmaceuticals?
GSK
Johnlee Pharmaceuticals Pvt. Ltd
Glenmark
Abbott
Takeda
IPR Pharmaceuticals
Lunan Better Pharmaceutical Co., Ltd
Nanjing Chia Tai Tianqing
Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd.
Zhejiang Jingxin Pharmaceutical
Zhejiang Haizheng
Hainan Tongyong Sanyang
Indian Biocon
With no less than 15 top producers.
Data including (both global and regions): Market Size (both volume - Box and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Box, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of Rosuvastatin
1.1 Definition and Specifications of Rosuvastatin
1.1.1 Definition of Rosuvastatin
1.1.2 Specifications of Rosuvastatin
1.1.2.1 5mg/Pill
1.1.2.2 10mg/Pill
1.1.2.3 20/Pill
1.1.2.4 Others
1.2 Classification of Rosuvastatin
1.2.1 Injection
1.2.2 Freeze-dried powder
1.3 Applications of Rosuvastatin
1.3.1 Hospital use
1.3.2 Clinic
1.3.3 Others
1.4 Industry Chain Structure of Rosuvastatin
1.5 Industry Overview and Major Regions Status of Rosuvastatin
1.5.1 Industry Overview of Rosuvastatin
1.5.2 Global Major Regions Status of Rosuvastatin
1.6 Industry Policy Analysis of Rosuvastatin
1.7 Industry News Analysis of Rosuvastatin
2 Manufacturing Cost Structure Analysis of Rosuvastatin
2.1 Raw Material Suppliers and Price Analysis of Rosuvastatin
2.2 Equipment Suppliers and Price Analysis of Rosuvastatin
2.3 Labor Cost Analysis of Rosuvastatin
2.4 Other Costs Analysis of Rosuvastatin
2.5 Manufacturing Cost Structure Analysis of Rosuvastatin
2.6 Manufacturing Process Analysis of Rosuvastatin
3 Technical Data and Manufacturing Plants Analysis of Rosuvastatin
3.1 Capacity and Commercial Production Date of Global Rosuvastatin Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Rosuvastatin Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Rosuvastatin Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Rosuvastatin Major Manufacturers in 2015
4 Global Rosuvastatin Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Rosuvastatin Capacity and Growth Rate Analysis
4.2.2 2015 Rosuvastatin Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Rosuvastatin Sales and Growth Rate Analysis
4.3.2 2015 Rosuvastatin Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Rosuvastatin Sales Price
4.4.2 2015 Rosuvastatin Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Rosuvastatin Gross Margin
4.5.2 2015 Rosuvastatin Gross Margin Analysis (Company Segment)
5 Rosuvastatin Regional Market Analysis
5.1 USA Rosuvastatin Market Analysis
5.1.1 USA Rosuvastatin Market Overview
5.1.2 USA 2011-2016E Rosuvastatin Local Supply, Import, Export, Local Consumption Analysis
5.1.3 USA 2011-2016E Rosuvastatin Sales Price Analysis
5.1.4 USA 2015 Rosuvastatin Market Share Analysis
5.2 China Rosuvastatin Market Analysis
5.2.1 China Rosuvastatin Market Overview
5.2.2 China 2011-2016E Rosuvastatin Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E Rosuvastatin Sales Price Analysis
5.2.4 China 2015 Rosuvastatin Market Share Analysis
5.3 UK Rosuvastatin Market Analysis
5.3.1 UK Rosuvastatin Market Overview
5.3.2 UK 2011-2016E Rosuvastatin Local Supply, Import, Export, Local Consumption Analysis
5.3.3 UK 2011-2016E Rosuvastatin Sales Price Analysis
5.3.4 UK 2015 Rosuvastatin Market Share Analysis
5.4 France Rosuvastatin Market Analysis
5.4.1 France Rosuvastatin Market Overview
5.4.2 France 2011-2016E Rosuvastatin Local Supply, Import, Export, Local Consumption Analysis
5.4.3 France 2011-2016E Rosuvastatin Sales Price Analysis
5.4.4 France 2015 Rosuvastatin Market Share Analysis
5.5 Switzerland Rosuvastatin Market Analysis
5.5.1 Switzerland Rosuvastatin Market Overview
5.5.2 Switzerland 2011-2016E Rosuvastatin Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Switzerland 2011-2016E Rosuvastatin Sales Price Analysis
5.5.4 Switzerland 2015 Rosuvastatin Market Share Analysis
5.6 Japan Rosuvastatin Market Analysis
5.6.1 Japan Rosuvastatin Market Overview
5.6.2 Japan 2011-2016E Rosuvastatin Local Supply, Import, Export, Local Consumption Analysis
5.6.3 Japan 2011-2016E Rosuvastatin Sales Price Analysis
5.6.4 Japan 2015 Rosuvastatin Market Share Analysis
5.7 Germany Rosuvastatin Market Analysis
5.7.1 Germany Rosuvastatin Market Overview
5.7.2 Germany 2011-2016E Rosuvastatin Local Supply, Import, Export, Local Consumption Analysis
5.7.3 Germany 2011-2016E Rosuvastatin Sales Price Analysis
5.7.4 Germany 2015 Rosuvastatin Market Share Analysis
5.8 Canada Rosuvastatin Market Analysis
5.8.1 Canada Rosuvastatin Market Overview
5.8.2 Canada 2011-2016E Rosuvastatin Local Supply, Import, Export, Local Consumption Analysis
5.8.3 Canada 2011-2016E Rosuvastatin Sales Price Analysis
5.8.4 Canada 2015 Rosuvastatin Market Share Analysis
6 Global 2011-2016E Rosuvastatin Segment Market Analysis (by Type)
6.1 Global 2011-2016E Rosuvastatin Sales by Type
6.2 Different Types Rosuvastatin Product Interview Price Analysis
6.3 Different Types Rosuvastatin Product Driving Factors Analysis
6.3.1 Injection Rosuvastatin Growth Driving Factor Analysis
6.3.2 Freeze-dried powder Rosuvastatin Growth Driving Factor Analysis
7 Global 2011-2016E Rosuvastatin Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Hospital use Rosuvastatin Growth Driving Factor Analysis
7.3.2 Clinic Rosuvastatin Growth Driving Factor Analysis
7.3.3 Others Rosuvastatin Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Rosuvastatin
8.1 Pfizer
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Pfizer 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Pfizer 2015 Rosuvastatin Business Region Distribution Analysis
8.2 Teva
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Teva 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Teva 2015 Rosuvastatin Business Region Distribution Analysis
8.3 AstraZeneca UK Limited
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 AstraZeneca UK Limited 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 AstraZeneca UK Limited 2015 Rosuvastatin Business Region Distribution Analysis
8.4 Novartis
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Novartis 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Novartis 2015 Rosuvastatin Business Region Distribution Analysis
8.5 Mylan
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Mylan 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Mylan 2015 Rosuvastatin Business Region Distribution Analysis
8.6 Squibb
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Squibb 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Squibb 2015 Rosuvastatin Business Region Distribution Analysis
8.7 Sandoz
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Sandoz 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Sandoz 2015 Rosuvastatin Business Region Distribution Analysis
8.8 Hikma Pharmaceuticals?
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Hikma Pharmaceuticals? 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Hikma Pharmaceuticals? 2015 Rosuvastatin Business Region Distribution Analysis
8.9 GSK
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 GSK 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 GSK 2015 Rosuvastatin Business Region Distribution Analysis
8.10 Johnlee Pharmaceuticals Pvt. Ltd
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Johnlee Pharmaceuticals Pvt. Ltd 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Johnlee Pharmaceuticals Pvt. Ltd 2015 Rosuvastatin Business Region Distribution Analysis
8.11 Glenmark
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Glenmark 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Glenmark 2015 Rosuvastatin Business Region Distribution Analysis
8.12 Abbott
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Abbott 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Abbott 2015 Rosuvastatin Business Region Distribution Analysis
8.13 Takeda
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Takeda 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Takeda 2015 Rosuvastatin Business Region Distribution Analysis
8.14 IPR Pharmaceuticals
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 IPR Pharmaceuticals 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 IPR Pharmaceuticals 2015 Rosuvastatin Business Region Distribution Analysis
8.15 Lunan Better Pharmaceutical Co., Ltd
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Lunan Better Pharmaceutical Co., Ltd 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Lunan Better Pharmaceutical Co., Ltd 2015 Rosuvastatin Business Region Distribution Analysis
8.16 Nanjing Chia Tai Tianqing
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Nanjing Chia Tai Tianqing 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Nanjing Chia Tai Tianqing 2015 Rosuvastatin Business Region Distribution Analysis
8.17 Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd.
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. 2015 Rosuvastatin Business Region Distribution Analysis
8.18 Zhejiang Jingxin Pharmaceutical
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 Zhejiang Jingxin Pharmaceutical 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Zhejiang Jingxin Pharmaceutical 2015 Rosuvastatin Business Region Distribution Analysis
8.19 Zhejiang Haizheng
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.3 Zhejiang Haizheng 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.19.4 Zhejiang Haizheng 2015 Rosuvastatin Business Region Distribution Analysis
8.20 Hainan Tongyong Sanyang
8.20.1 Company Profile
8.20.2 Product Picture and Specifications
8.20.3 Hainan Tongyong Sanyang 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.20.4 Hainan Tongyong Sanyang 2015 Rosuvastatin Business Region Distribution Analysis
8.21 Indian Biocon
8.21.1 Company Profile
8.21.2 Product Picture and Specifications
8.21.3 Indian Biocon 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.21.4 Indian Biocon 2015 Rosuvastatin Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 USA 2016-2021 Rosuvastatin Consumption Forecast
9.2.2 China 2016-2021 Rosuvastatin Consumption Forecast
9.2.3 UK 2016-2021 Rosuvastatin Consumption Forecast
9.2.4 France 2016-2021 Rosuvastatin Consumption Forecast
9.2.5 Switzerland 2016-2021 Rosuvastatin Consumption Forecast
9.2.6 Japan 2016-2021 Rosuvastatin Consumption Forecast
9.2.7 Germany 2016-2021 Rosuvastatin Consumption Forecast
9.2.8 Canada 2016-2021 Rosuvastatin Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Rosuvastatin Marketing Model Analysis
10.1 Rosuvastatin Regional Marketing Model Analysis
10.2 Rosuvastatin International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Rosuvastatin by Regions
10.4 Rosuvastatin Supply Chain Analysis
11 Consumers Analysis of Rosuvastatin
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Rosuvastatin
12.1 New Project SWOT Analysis of Rosuvastatin
12.2 New Project Investment Feasibility Analysis of Rosuvastatin
13 Conclusion of the Global Rosuvastatin Market Professional Survey Report 2016
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
